Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
28 November 2012 | By Novartis
More than 140 presentations on key data...
List view / Grid view
28 November 2012 | By Novartis
More than 140 presentations on key data...
28 November 2012 | By GlaxoSmithKline
GSK welcomes the publication of the third Access to Medicines (ATM) Index...
28 November 2012 | By Catalent Pharma Solutions
Jeffrey E. Browne at Catalent Pharma Solutions will be presenting...
28 November 2012 | By Pfizer
Pfizer Inc. announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc..
28 November 2012 | By Abbott
Abbott board of directors approved the separation of its research-based pharmaceuticals business...
27 November 2012 | By kdm communications limited
Tecan has developed an AlphaScreen® module for its popular Infinite® F200 PRO multimode reader...
27 November 2012 | By kdm communications limited
LoGiCal® reference materials from LGC Standards have enabled Spark Holland to establish an online SPE-LC/MSMS method...
27 November 2012 | By Novo Nordisk
New data analyses...
27 November 2012 | By Abbott
Abbott announced that the European Commission has approved HUMIRA®...
27 November 2012 | By Gilead Sciences, Inc.
Gilead Sciences announced that the European Commission has granted marketing authorization for two new indications for once-daily Viread®...
27 November 2012 | By Merck
Novel personalized treatment approach targets folate receptors on cancer cells...
27 November 2012 | By Gilead Sciences
Gilead Sciences announced topline results from the Phase 3 POSITRON study...
26 November 2012 | By GlaxoSmithKline
GSK and GSK Nigeria have reached agreement...
20 November 2012 | By Novartis
The US FDA approved the use of Flucelvax®...
20 November 2012 | By GlaxoSmithKline
GSK will be a headline partner at the Coronation Festival...